OCUP - Ocuphire Pharma GAAP EPS of $1.58 beats by $0.15 revenue of $39.85M beats by $11.79M
2023-03-30 08:25:36 ET
- Ocuphire Pharma press release ( NASDAQ: OCUP ): Q4 GAAP EPS of $1.58 beats by $0.15 .
- Revenue of $39.85M beats by $11.79M .
- As of December 31, 2022, Ocuphire had cash and cash equivalents of approximately $42.6 million. The Company has no debt. Based on current projections, management believes the present cash on hand will be sufficient to fund operations into 2025.
For further details see:
Ocuphire Pharma GAAP EPS of $1.58 beats by $0.15, revenue of $39.85M beats by $11.79M